Provider Resources
Our Protocols
Psychedelic therapy is emerging as a promising option for patients with treatment-resistant conditions. These resources are to help you navigate safe and appropriate referrals.
Identifying prospective clinical trial candidates
Learn what clinical trial participation involves and whether it aligns with your needs, goals, and circumstances.
Our approach to safety in psychedelic therapy
Discover how our comprehensive care model protects both physical and psychological well-being.
Safety, agency, and recovery: trauma-informed care at Sunstone
Continuous informed consent, psychological safety, and individualized care are built into every step of the treatment process.
Advancing standards in MDMA psychedelic therapy research training
We are setting the industry standard for high quality training for mental health professionals in psychedelic therapy research.
Meet Dr. Manish Agrawal – Psychedelic Oncology Leader
Manish Agrawal, MD, brings an extensive academic, clinical, and research background and depth of experience to Sunstone.
Psychedelic Therapy
In psychedelic-assisted therapy, these medicines are administered by professional therapists who provide a sense of safety and guidance throughout the process as the patient prepares for, undergoes, and integrates their psychedelic experience.
Applying trauma-informed care in psychedelic therapy
Trauma-informed care recognizes the lasting effects trauma can have on a person’s emotions, relationships, body, and sense of safety.
How psychedelic-assisted therapy may complement ongoing mental health care
As psychedelic-assisted therapies continue advancing through clinical research, understanding how they fit within existing mental health care systems is increasingly important.
How psychedelic treatment could transform veteran care
Why veterans’ trauma requires new therapeutic approaches.
Research explores how psilocybin-assisted group therapy addresses existential distress in cancer patients
New findings that deepen understanding of how psilocybin-assisted group therapy can help people with cancer and depression.
Sunstone’s 2Dose Study: Advancing psilocybin-assisted therapy in cancer care
This clinical trial will explore whether psilocybin is more effective than an active placebo and if two doses are better than one.
View All
Published Research
Explore our growing list of published research on psychedelic-assisted therapy featured in medical journals and publications.
Set and setting in psilocybin-assisted therapy
General Hospital Psychiatry
Can research, data, and technology aid the development of psychedelic medicine?
Journal of Psychopharmacology, Jan 2022.
The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder
Journal of Clinical Oncology, June 2022.
Psilocybin-assisted therapy improves psychosocial well-being in cancer patients
Journal of Affective Disorders, Dec 2022.
Psilocybin therapy for patients with cancer and major depression disorder
JAMA Oncology, April 2023.
View All
Explore Clinical Trials
Sunstone Therapies’ clinical trials use evidence-informed psychedelic therapies to address cancer-related grief, PTSD, depression, trauma, and more. Discover how these studies are structured, monitored, and supported by licensed professionals.
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD (SUN004)
Psilocybin
Rockville, MD
Sunstone Medical
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Psilocybin Analog: RE104
Rockville, MD
Reunion Neuroscience
A Clinical Study of Psilocybin Therapy Addressing Demoralization and Loss of Meaning
Psilocybin
Rockville, MD
Lundquist Institute at Harbor-UCLA Medical Center
Meet Our Clinical Team
Our Hiring Practices
At Sunstone Therapies, we uphold the highest standards in vetting and hiring clinical staff to ensure exceptional patient care and safety. Every team member undergoes a rigorous selection process that includes credential verification and clinical experience review.
Refer a Patient
With a highly experienced and professional staff, we prioritize safety, informed consent, and comprehensive support to ensure optimal care in collaboration with referring physicians.
Refer a Patient